178 related articles for article (PubMed ID: 26418895)
41. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
[TBL] [Abstract][Full Text] [Related]
42. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
Hassan E; Galal K; Esmat E
Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797
[TBL] [Abstract][Full Text] [Related]
43. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
44. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
45. Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer.
Miah AB; Bhide SA; Del Rosario L; Matthews J; Nicol R; Tanay MA; Gupta S; Zaidi SH; Newbold KL; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e61-7. PubMed ID: 26876458
[TBL] [Abstract][Full Text] [Related]
46. Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Chen Z; Long X; Pang Q; Peng L; Li X; Gu J; Deng S; Xing L
Oncol Res; 2022 Jan; 28(9):929-944. PubMed ID: 34544526
[TBL] [Abstract][Full Text] [Related]
47. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
[TBL] [Abstract][Full Text] [Related]
48. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ
Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427
[TBL] [Abstract][Full Text] [Related]
49. Salvage Re-irradiation with Intensity-modulated Radiotherapy, Chemotherapy Combined with Hyperthermia for Local Recurrence of Nasopharyngeal Carcinoma After Chemoradiotherapy.
Morisaki T; Ohguri T; Yahara K; Nakahara S; Kakinouchi S; Itamura H; Wakasugi T; Suzuki H; Korogi Y
J UOEH; 2021; 43(3):355-361. PubMed ID: 34483195
[TBL] [Abstract][Full Text] [Related]
50. Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma.
Li YC; Chen FP; Zhou GQ; Zhu JH; Hu J; Kang DH; Wu CF; Lin L; Wang XJ; Ma J; Sun Y
Oral Oncol; 2017 Oct; 73():97-104. PubMed ID: 28939083
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
Maimaitiming N; Ma X; Wei Y; Cao L; Gao Y; Zhang L
Medicine (Baltimore); 2022 Sep; 101(36):e30170. PubMed ID: 36086700
[TBL] [Abstract][Full Text] [Related]
52. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.
Wen QL; Meng MB; Yang B; Tu LL; Jia L; Zhou L; Xu Y; Lu Y
Cancer Sci; 2009 Aug; 100(8):1510-9. PubMed ID: 19459845
[TBL] [Abstract][Full Text] [Related]
53. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
[TBL] [Abstract][Full Text] [Related]
54. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
Liang G; Du W; Ke Q; Huang B; Yang J
Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
[TBL] [Abstract][Full Text] [Related]
55. Five-year survival rate analysis: the combination of fortnightly-administration of endostar and concurrent chemoradiotherapy versus concurrent chemoradiotherapy in the treatment of inoperable locally advanced non-small cell lung cancer.
Ma H; Peng F; Xu Y; Bao Y; Hu X; Wang J; Fang M; Kong Y; Dong B; Chen M
Ann Palliat Med; 2021 Jul; 10(7):7560-7570. PubMed ID: 34353044
[TBL] [Abstract][Full Text] [Related]
56. Endostar (rh-endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
Yuan M; Zhai Y; Men Y; Wang J; Deng L; Wang W; Bao Y; Yang X; Sun S; Ma Z; Liu Y; Wang J; Zhu H; Hui Z
Thorac Cancer; 2021 Dec; 12(23):3208-3215. PubMed ID: 34676669
[TBL] [Abstract][Full Text] [Related]
57. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma.
Ma WS; Ma JG; Xing LN
Anticancer Drugs; 2017 Feb; 28(2):230-236. PubMed ID: 27775992
[TBL] [Abstract][Full Text] [Related]
59. Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.
Xing P; Zhang J; Yan Z; Zhao G; Li X; Wang G; Yang Y; Zhao J; Xing R; Teng S; Ma Y; Liao Z; Ren Z; Zhang C; Han X; Zhang W; Chen K; Wang P; Yang J
Oncotarget; 2017 May; 8(22):36716-36727. PubMed ID: 27888623
[TBL] [Abstract][Full Text] [Related]
60. Early efficacy of Endostar combined with chemoradiotherapy for advanced cervical cancers.
Ke QH; Zhou SQ; Huang M; Lei Y; Du W; Yang JY
Asian Pac J Cancer Prev; 2012; 13(3):923-6. PubMed ID: 22631672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]